Life Science REIT PLC (LABS)

Category Property - Direct UK


Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

38.50p

Buy

39.00p

arrow-up0.20p (+0.52%)

Discount/Premium

-42.56%

Estimated NAV

67.552p

Prices updated at 12 Dec 2025, 16:38 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

arrow-down-0.48%
LSE

38.60
Launch date19 Nov 2021
39.00p - 38.60p
49.00p - 32.52p
66.60 as of 30 Jun 2025
Ongoing charge audited (%)1.8
2.55
0.00
3.06
712,866.13
350.00m
135.80m
143.98
Semi-Annually
£345.13m
£228.55m
-41.62
-44.69
-39.55
Fund comparative indexNo benchmark
SA
0.78m
0.31m
GB00BP5X4Q29
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.